Model: Treating "super spreaders" can slow HCV transmission

02/1/2013 |

An injection drug user with hepatitis C can be expected to spread the illness to 20 other people, according to a study from the University of Oxford in England. The model-based research underscores the value of early diagnosis and treatment, and similar methods could be useful in addressing HIV, the study's author said.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT